Emerging Role of Medicare Advantage in Nursing Home Care
医疗保险优势在疗养院护理中的新兴作用
基本信息
- 批准号:8673221
- 负责人:
- 金额:$ 44.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectCaringCharacteristicsChronically IllClinical DataComplexCost SavingsDataData ReportingData SetDecubitus ulcerDiscipline of NursingEnrollmentEvaluationFee-for-Service PlansGoalsGrowthHealthcareHome Nursing CareHospitalizationImProvIncidenceIndividualInvestigationKnowledgeLinkLong-Term CareManaged CareMarketingMedicalMedicareModernizationMorbidity - disease rateNurse PractitionersNursing HomesOutcomePatientsPoliciesPopulationProbabilityProcessProviderPublishingRecordsResearchRiskRoleServicesTimebeneficiarycapitate bonedual eligibleexperiencefederal policyimprovedmembermortalitynursing home length of staypaymentprogramspublic health relevancerestraint
项目摘要
DESCRIPTION (provided by applicant): For over 25 years, Medicare policy has promoted beneficiaries' enrollment in private, risk-bearing plans, currently known as Medicare Advantage (MA) plans. The 2006 Medicare Modernization Act (MMA) increased MA payments and compensated plans for serving more medically complex and frail beneficiaries, stimulating a doubling of the MA population over the past 8 years. This explosive growth in MA enrollment has also occurred among nursing home residents; however, we know virtually nothing about the quality and outcomes of care among nursing home residents in private, managed care plans. This lack of knowledge compromises our ability to understand the implications of expansions of special needs and dual eligible MA plans included in the Affordable Care Act (ACA). Because the Medicare program spends $115 billion in annual capitated payments to MA plans, understanding their emerging role in caring for frail, chronically ill beneficiaries is critical to
inform optimal federal policy. Between 2000 and 2010 the prevalent population of MA plan members in nursing homes increased from about 16,000 to 80,000 (about 8% of all long stay residents). Half of these individuals reside in only 500 nursing facilities, each with more than 75
MA plan members. United Healthcare's "Evercare" program, which provides integrated medical care and care management services to MA plan beneficiaries residing in nursing homes, was associated with lower mortality, fewer preventable hospitalizations, and cost- savings of approximately $100,000 per year per nurse practitioner. Of note, Evercare was initiated before the MMA and the subsequent growth of MA plans' use of nursing homes for post-acute and long term care patients. The long-term objective of this research is to inform policy efforts to improv the quality and outcomes of care for vulnerable nursing home residents. The objective of this application, which is the next step in our long-range goal, is to examine the impact of Medicare Advantage plans on the care of nursing home residents, both among residents enrolled in these plans as well as on non-MA residents via "spill-over" effects. The rationale that underlies this investigation is that MA plans have assumed a rapidly growing role in the care of nursing home residents with little knowledge about how managed care may impact this frail, chronically-ill population. Our central hypothesis, which is informed by the results of the Evercare evaluation and the paucity of other studies, is that integrated medical cares in the nursing home setting, particularly in facilities where MA plan residents are concentrated, positively affect patient outcomes. We propose to undertake a comprehensive examination of the growth of these plans and their impact on nursing home care using 15 years (2000 through 2014) of data on MA plans' use of nursing facilities that integrates Medicare enrollment records, HEDIS data reported to CMS, and the mandatory nursing home resident assessment minimum data set (MDS).
描述(由申请人提供):25 年来,Medicare 政策一直在促进受益人加入私人风险承担计划,目前称为 Medicare Advantage (MA) 计划。 2006 年《医疗保险现代化法案》(MMA) 增加了 MA 付款和补偿计划,为医疗状况更复杂和体弱的受益人提供服务,刺激 MA 人口在过去 8 年翻了一番。护理院居民中也出现了 MA 入学人数的爆炸式增长;然而,我们对私人管理式护理计划中疗养院居民的护理质量和结果几乎一无所知。这种知识的缺乏损害了我们理解平价医疗法案 (ACA) 中包含的特殊需求和双重合格 MA 计划的影响的能力。由于 Medicare 计划每年向 MA 计划支付 1,150 亿美元的人均付款,因此了解其在照顾体弱的慢性病受益人方面的新兴作用对于
告知最佳联邦政策。 2000 年至 2010 年间,疗养院的 MA 计划成员人数从约 16,000 人增加到 80,000 人(约占所有长期居住居民的 8%)。其中一半人居住在仅 500 个护理机构中,每个机构都有超过 75 名护理人员
MA计划成员。 United Healthcare 的“Evercare”计划为居住在疗养院的 MA 计划受益人提供综合医疗护理和护理管理服务,该计划可降低死亡率、减少可预防的住院治疗,并且每位执业护士每年可节省约 100,000 美元的成本。值得注意的是,Evercare 是在 MMA 之前启动的,随后 MA 计划越来越多地使用疗养院来治疗急性期后和长期护理患者。 这项研究的长期目标是为政策努力提供信息,以提高弱势疗养院居民的护理质量和结果。此应用程序是我们长期目标的下一步,其目的是检查 Medicare Advantage 计划对疗养院居民护理的影响,包括参加这些计划的居民以及非 MA 居民通过“溢出”效应。这项调查的基本原理是,MA 计划在疗养院居民的护理方面发挥着迅速增长的作用,但人们对管理式护理可能如何影响这些虚弱的慢性病人群知之甚少。我们的中心假设是,基于 Evercare 评估结果和其他研究的缺乏,我们的中心假设是,疗养院环境中的综合医疗护理,特别是在 MA 计划居民集中的设施中,会对患者的治疗结果产生积极影响。我们建议使用 15 年(2000 年至 2014 年)MA 计划使用护理设施的数据(整合了 Medicare 登记记录、向 CMS 报告的 HEDIS 数据、以及强制性疗养院居民评估最低数据集(MDS)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vincent Mor其他文献
Vincent Mor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vincent Mor', 18)}}的其他基金
METRIcAL - Music & MEmory: a Pragmatic TRIal for Nursing Home Residents with ALzheimer's Disease
韵律 - 音乐
- 批准号:
9792233 - 财政年份:2017
- 资助金额:
$ 44.99万 - 项目类别:
METRIcAL - Music & MEmory: a Pragmatic TRIal for Nursing Home Residents with ALzheimer's Disease
韵律 - 音乐
- 批准号:
10219946 - 财政年份:2017
- 资助金额:
$ 44.99万 - 项目类别:
The Effect of Reduction and Standardization of Reimbursements in the VA Fee-Basis Program: Impact on Quality of Care and Health Outcomes
VA 收费计划中报销减少和标准化的效果:对护理质量和健康结果的影响
- 批准号:
9757710 - 财政年份:2017
- 资助金额:
$ 44.99万 - 项目类别:
Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS
护理人员的反应和经验:淀粉样蛋白扫描的痴呆症影像证据 护理理念
- 批准号:
9316753 - 财政年份:2016
- 资助金额:
$ 44.99万 - 项目类别:
Emerging Role of Medicare Advantage in Nursing Home Care
医疗保险优势在疗养院护理中的新兴作用
- 批准号:
8874822 - 财政年份:2014
- 资助金额:
$ 44.99万 - 项目类别:
Advancing Long -Term Care Research by Linking HRS and LTC Focus
通过将 HRS 和 LTC 焦点联系起来推进长期护理研究
- 批准号:
8619396 - 财政年份:2013
- 资助金额:
$ 44.99万 - 项目类别:
Advancing Long -Term Care Research by Linking HRS and LTC Focus
通过将 HRS 和 LTC 焦点联系起来推进长期护理研究
- 批准号:
8738574 - 财政年份:2013
- 资助金额:
$ 44.99万 - 项目类别:
相似国自然基金
TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
- 批准号:52361020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
- 批准号:52309088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
- 批准号:42376002
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
- 批准号:42371397
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
I-TRANSFER-HF: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe: A Type 1 Hybrid Effectiveness Implementation Trial
I-TRANSFER-HF:改善家庭医疗保健中心力衰竭患者的过渡和结果:1 型混合有效性实施试验
- 批准号:
10714524 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures
用于治疗和预防耐药性癫痫发作的研究性 WNT 通路调节剂
- 批准号:
10725450 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别: